EFS-AsCpf1 AAV (Serotype 9)

EFS-AsCpf1 AAV (serotype 9) represents a cutting-edge genetic tool for precision genome editing. Pre-made serotype 9 AAV particles are engineered to express the AsCpf1 nuclease under the control of the EFS promoter. The AsCpf1 nuclease is a CRISPR-associated protein that has attracted much attention for its unique properties in genome editing. Unlike the more well-known Cas9, AsCpf1 has unique advantages, including a smaller size and a staggered DNA cleavage pattern, which facilitates cleaner and more precise genetic modifications. This makes it particularly attractive for therapeutic applications where precision is critical.

The EFS promoter (elongation factor-1α short promoter) ensures stable expression of the AsCpf1 nuclease. Known for its high efficiency and broad expression in various cell types, the EFS promoter enables constant and stable expression of the AsCpf1 protein, thereby optimizing the efficiency of genome editing tasks. Adeno-associated virus (AAV) serotype 9 was selected for its superior transduction capabilities across a wide range of tissues, including cardiac, muscle, and central nervous system tissues, making it an excellent choice for research and therapeutic applications targeting these areas. The excellent tissue tropism of AAV9 enhances the potential reach and efficacy of the AsCpf1 system, enabling it to penetrate hard-to-reach cells and efficiently deliver its genetic payload.